FR2451911A1 - Nouveaux derives de la forphenicine presentant une activite immuno-potentialisatrice et procede pour sa preparation - Google Patents

Nouveaux derives de la forphenicine presentant une activite immuno-potentialisatrice et procede pour sa preparation

Info

Publication number
FR2451911A1
FR2451911A1 FR7907715A FR7907715A FR2451911A1 FR 2451911 A1 FR2451911 A1 FR 2451911A1 FR 7907715 A FR7907715 A FR 7907715A FR 7907715 A FR7907715 A FR 7907715A FR 2451911 A1 FR2451911 A1 FR 2451911A1
Authority
FR
France
Prior art keywords
forphenicin
potentializing
immuno
activity
derivatives
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
FR7907715A
Other languages
English (en)
Other versions
FR2451911B1 (fr
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Microbial Chemistry Research Foundation
Original Assignee
Microbial Chemistry Research Foundation
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority to JP10893677A priority Critical patent/JPS5444632A/ja
Priority to GB7909188A priority patent/GB2043625B/en
Priority to US06/021,222 priority patent/US4238507A/en
Priority to CA323,698A priority patent/CA1124261A/fr
Application filed by Microbial Chemistry Research Foundation filed Critical Microbial Chemistry Research Foundation
Priority to FR7907715A priority patent/FR2451911A1/fr
Priority to DE2911377A priority patent/DE2911377C3/de
Priority to IT799378A priority patent/IT1165945B/it
Publication of FR2451911A1 publication Critical patent/FR2451911A1/fr
Application granted granted Critical
Publication of FR2451911B1 publication Critical patent/FR2451911B1/fr
Granted legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D319/00—Heterocyclic compounds containing six-membered rings having two oxygen atoms as the only ring hetero atoms
    • C07D319/04—1,3-Dioxanes; Hydrogenated 1,3-dioxanes
    • C07D319/08—1,3-Dioxanes; Hydrogenated 1,3-dioxanes condensed with carbocyclic rings or ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D317/00—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms
    • C07D317/08—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3
    • C07D317/44—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D317/46—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 ortho- or peri-condensed with carbocyclic rings or ring systems condensed with one six-membered ring
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

CE COMPOSE NOUVEAU, DENOMME MAINTENANT FORPHENICINOL, A POUR FORMULE: (CF DESSIN DANS BOPI) ET PRESENTE UNE ACTIVITE IMMUNO-POTENTIALISATRICE. CE COMPOSE ET SES SELS ET HYDRATES PHARMACEUTIQUEMENT ACCEPTABLES SONT UTILES EN IMMUNITHERAPIE ET POUR LE TRAITEMENT DE MALADIES ET DE TROUBLES IMMUNITAIRES CHEZ L'HOMME ET LES ANIMAUX. ON PEUT PREPARER CE COMPOSE PAR HYDROLYSE DU COMPOSE AMINONITRILE CORRESPONDANT, DE FORMULE: (CF DESSIN DANS BOPI) OU PAR REDUCTION DE LA FORPHENICINE.
FR7907715A 1977-09-12 1979-03-21 Nouveaux derives de la forphenicine presentant une activite immuno-potentialisatrice et procede pour sa preparation Granted FR2451911A1 (fr)

Priority Applications (7)

Application Number Priority Date Filing Date Title
JP10893677A JPS5444632A (en) 1977-09-12 1977-09-12 Novel compound with immunization activity and its preparation and application
GB7909188A GB2043625B (en) 1977-09-12 1979-03-15 Forphenicinol
US06/021,222 US4238507A (en) 1977-09-12 1979-03-16 Pharmacological compound with immunopotentiating activity and production and uses thereof
CA323,698A CA1124261A (fr) 1977-09-12 1979-03-19 Compose pharmaceutique stimulant les reactions immunitaires et methode de production
FR7907715A FR2451911A1 (fr) 1977-09-12 1979-03-21 Nouveaux derives de la forphenicine presentant une activite immuno-potentialisatrice et procede pour sa preparation
DE2911377A DE2911377C3 (de) 1977-09-12 1979-03-23 3-Hydroxy-4-hydroxymethyl-phenylglycin (Forphenicinol), dessen Hydrate und Salze, Verfahren zu deren Herstellung und diese Verbindungen enthaltende Arzneimittel
IT799378A IT1165945B (it) 1977-09-12 1979-03-23 Composto farmacologico con attivita immunopotenziante e produzione ed usi di esso

Applications Claiming Priority (7)

Application Number Priority Date Filing Date Title
JP10893677A JPS5444632A (en) 1977-09-12 1977-09-12 Novel compound with immunization activity and its preparation and application
GB7909188A GB2043625B (en) 1977-09-12 1979-03-15 Forphenicinol
US06/021,222 US4238507A (en) 1977-09-12 1979-03-16 Pharmacological compound with immunopotentiating activity and production and uses thereof
CA323,698A CA1124261A (fr) 1977-09-12 1979-03-19 Compose pharmaceutique stimulant les reactions immunitaires et methode de production
FR7907715A FR2451911A1 (fr) 1977-09-12 1979-03-21 Nouveaux derives de la forphenicine presentant une activite immuno-potentialisatrice et procede pour sa preparation
DE2911377A DE2911377C3 (de) 1977-09-12 1979-03-23 3-Hydroxy-4-hydroxymethyl-phenylglycin (Forphenicinol), dessen Hydrate und Salze, Verfahren zu deren Herstellung und diese Verbindungen enthaltende Arzneimittel
IT799378A IT1165945B (it) 1977-09-12 1979-03-23 Composto farmacologico con attivita immunopotenziante e produzione ed usi di esso

Publications (2)

Publication Number Publication Date
FR2451911A1 true FR2451911A1 (fr) 1980-10-17
FR2451911B1 FR2451911B1 (fr) 1982-12-10

Family

ID=32996652

Family Applications (1)

Application Number Title Priority Date Filing Date
FR7907715A Granted FR2451911A1 (fr) 1977-09-12 1979-03-21 Nouveaux derives de la forphenicine presentant une activite immuno-potentialisatrice et procede pour sa preparation

Country Status (7)

Country Link
US (1) US4238507A (fr)
JP (1) JPS5444632A (fr)
CA (1) CA1124261A (fr)
DE (1) DE2911377C3 (fr)
FR (1) FR2451911A1 (fr)
GB (1) GB2043625B (fr)
IT (1) IT1165945B (fr)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5513238A (en) * 1978-07-17 1980-01-30 Banyu Pharmaceut Co Ltd Novel compound having immunoactivating action, its preparation and application
DE3002543A1 (de) * 1980-01-25 1981-07-30 Basf Ag, 6700 Ludwigshafen 4-tert.-butoxyphenylglycinnitril sowie verfahren zur herstellung von d-(-)- und l-(+)-4-hydroxyphenylglycin
US7888372B2 (en) * 2001-03-23 2011-02-15 National Institutes Of Health (Nih) Compositions and methods for modulating bone mineral deposition

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3891634A (en) * 1970-12-17 1975-06-24 Smithkline Corp P-Hydroxymethylphenylacetamidocephalosporins
US3904680A (en) * 1972-12-22 1975-09-09 Colgate Palmolive Co L-3-hydroxymethyltyrosine and salts thereof

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3395176A (en) * 1964-03-06 1968-07-30 Merck & Co Inc Alpha-hydroxymethylphenylalanine compounds
US3825590A (en) * 1972-02-25 1974-07-23 Colgate Palmolive Co Hydroxy-hydroxymethyl-substituted phenylalanine derivatives

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3891634A (en) * 1970-12-17 1975-06-24 Smithkline Corp P-Hydroxymethylphenylacetamidocephalosporins
US3904680A (en) * 1972-12-22 1975-09-09 Colgate Palmolive Co L-3-hydroxymethyltyrosine and salts thereof

Also Published As

Publication number Publication date
DE2911377B2 (de) 1981-02-05
GB2043625A (en) 1980-10-08
IT7909378A0 (it) 1979-03-23
CA1124261A (fr) 1982-05-25
GB2043625B (en) 1983-02-23
JPS5761265B2 (fr) 1982-12-23
US4238507A (en) 1980-12-09
FR2451911B1 (fr) 1982-12-10
IT1165945B (it) 1987-04-29
DE2911377C3 (de) 1982-03-18
JPS5444632A (en) 1979-04-09
DE2911377A1 (de) 1980-09-25

Similar Documents

Publication Publication Date Title
FR2383157A1 (fr) Derives de chalcone, leur procede de preparation et leur application en therapeutique
NO821494L (no) Terapeutisk nyttige 1-alkyl-2-aminotetralinderivater
FR2381028A1 (fr) Derives d'acide benzoique, leur procede de preparation et leur application en therapeutique
MD921G2 (ro) Derivaţi arilpropionici, procedeu de obţinere a lor şi compoziţie farmaceutică pe baza lor
FR2453155A1 (fr) Derives de cyanoguanidine, leur procede de preparation et leurs applications en therapeutique
BE849697A (fr) Procede de preparation d'anhydrides d'acides carboxyliques
FR2400500A1 (fr) Derives d'acides cycloalcoylidenemethylphenylacetiques, leur procede de preparation et leur application en therapeutique
FR2380285A1 (fr) Nouveaux derives insatures d'acides 7-acylamido-3-cephem-4-carboxyliques, utiles notamment comme agents antibacteriens, et leur procede de preparation
FR2398713A1 (fr) Procede pour la preparation d'acides a-hydroxycarboxyliques optiquement actifs
FR2355796A1 (fr) Procede de preparation de fluorures d'acides perfluoro-alcoxy-propioniques
FR2418797A1 (fr) Nouveaux derives heterocycliques d'acide acetique, leur procede de preparation et leur application en therapeutique
FR2453151A1 (fr) Derives de la vitamine d3, leur procede de preparation et leur application en therapeutique
FR2417502A1 (fr) Nouvelles 2-phenylimino-imidazolidines substituees, leurs sels d'addition avec des acides, medicaments les renfermant et procedes pour leur preparation
FR2392959A1 (fr) Amino-acides et procede d'obtention
FR2451911A1 (fr) Nouveaux derives de la forphenicine presentant une activite immuno-potentialisatrice et procede pour sa preparation
FR2456097A1 (fr) Nouveaux derives de la 5 h-furanone-2 et de la 3 h-dihydrofuranone-2, leur procede de preparation et leur application en therapeutique
FR2355831A1 (fr) Derives de benzazocine, leur procede de preparation et leur application therapeutique
FR2306192A1 (fr) Procede de preparation d'acides arylpropioniques
FR2446831A1 (fr) Derive oxyimino-e-homo-eburnane, procede pour le preparer et son utilisation dans une composition pharmaceutique pour la preparation de derives ester de l'acide apovincaminique
FR2383943A1 (fr) Triazinones, leur procede de preparation et leur application en therapeutique
BE868981A (fr) Procede de preparation d'alcoylesters d'acides carboxyliques
FR2356658A1 (fr) Procede de production d'acides phosphinico-carboxyliques aliphatiques substitues
BE865480A (fr) Procede pour la preparation d'acides naphtylaminohydroxysulfoniques
FR2473507B1 (fr) Procede de production d'acides arylpropioniques
FR2376190A1 (fr) Procede de preparation de pigments azoiques

Legal Events

Date Code Title Description
ST Notification of lapse